Pharmacotherapy of arterial hypertension in patients with psoriasis
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00843989%3A_____%2F25%3AE0111531" target="_blank" >RIV/00843989:_____/25:E0111531 - isvavai.cz</a>
Alternative codes found
RIV/61988987:17110/25:A2603DG4
Result on the web
<a href="https://journals.lww.com/jhypertension/fulltext/2025/04000/pharmacotherapy_of_arterial_hypertension_in.2.aspx" target="_blank" >https://journals.lww.com/jhypertension/fulltext/2025/04000/pharmacotherapy_of_arterial_hypertension_in.2.aspx</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1097/HJH.0000000000003982" target="_blank" >10.1097/HJH.0000000000003982</a>
Alternative languages
Result language
angličtina
Original language name
Pharmacotherapy of arterial hypertension in patients with psoriasis
Original language description
Psoriasis is a chronic systemic autoimmune disease associated with an elevated risk of developing cardiovascular disease. In patients with psoriasis, arterial hypertension treatment requires careful selection of antihypertensive drugs, as some drugs may worsen the skin manifestations of psoriasis. In this review, we summarize the available evidence regarding the risks and benefits of each group of antihypertensive drugs. We also suggest a scheme for optimizing antihypertensive treatment in patients with psoriasis, with emphasis on achieving effective control of blood pressure and cardiovascular disease, while minimizing the worsening of cutaneous manifestations. Angiotensin receptor blockers appear to be the most appropriate treatment for hypertensive patients with psoriasis, with the potential addition of calcium channel blockers if blood pressure is not adequately controlled. Alternatives are angiotensin-converting enzyme inhibitors and/or mineralocorticoid receptor antagonists. Diuretics and beta blockers are associated with greater risk of worsening of psoriatic lesions.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of hypertension
ISSN
0263-6352
e-ISSN
1473-5598
Volume of the periodical
43
Issue of the periodical within the volume
4
Country of publishing house
GB - UNITED KINGDOM
Number of pages
9
Pages from-to
568-576
UT code for WoS article
001429352400023
EID of the result in the Scopus database
2-s2.0-85218827110